The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Hepatologist, Transplant hepatologist
Associate Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center
Bio:
Dr. Nguyen is a clinician investigator. She is currently Associate Professor of Medicine and Director for the Hepatology Fellowship in the Division of Gastroenterology and Hepatology and Liver Transplant Program at Stanford University Medical Center and Director for the Hepatology Clerkship for Stanford University School of Medicine. She is also a member of the Stanford Cancer Institute and Bio-X and a Fellow of the American Association for the Study of Liver Diseases.
She has a large and comprehensive practice of general liver as well as liver transplant patients at Stanford University Medical Center and 3 outreach clinics in the San Jose and Los Gatos areas. Her research areas include epidemiology, clinical outcomes, translational studies, and therapeutic clinical trials for chronic hepatitis B, chronic hepatitis C, liver cancer/tumors, other chronic liver diseases as cause of liver cancer such as nonalcoholic fatty liver disease and liver transplant-related issues. Her research lab includes trainees who are undergraduate students, medical students, graduate students in the Masters' in Epidemiology Program, interns/residents, gastroenterology/hepatology fellows, junior faculty, and visiting scholars. She also serves as Pre-Major Academic Advisor for the undergraduate school.
Her research base includes single-center Stanford-based cohorts, multi-center Bay Area consortium, multi-center US consortia as well as collaborative international cohorts.
She is active in community outreach efforts locally and nationally including service as executive board of director for nonprofit organizations. She serves in the Education and Hepatology Associate Committees for the American Association for the Study of Liver Diseases (AASLD), as member of the Steering Committee for the Hepatobiliary Neoplasia Special Interest Group at AASLD, and has served as member of the Editorial Board for various journals including Gastroenterology.
Dr. Nguyen is also active in Global Health with research collaboration and medical education program and exchanges, with ongoing work in and with several countries in the Asia Pacific region. She is Senior Fellow at the Center for Innovation in Global Health at Stanford University.
She is a Fellow of the American Association for the Study of Liver Diseases and American Gastroenterological Association Fellow, She is also a member of the European Association for the Study of Liver Diseases, the Asia Pacific Association for the Study of Liver Diseases, and the International Liver Cancer Association.
She has a large and comprehensive practice of general liver as well as liver transplant patients at Stanford University Medical Center and 3 outreach clinics in the San Jose and Los Gatos areas. Her research areas include epidemiology, clinical outcomes, translational studies, and therapeutic clinical trials for chronic hepatitis B, chronic hepatitis C, liver cancer/tumors, other chronic liver diseases as cause of liver cancer such as nonalcoholic fatty liver disease and liver transplant-related issues. Her research lab includes trainees who are undergraduate students, medical students, graduate students in the Masters' in Epidemiology Program, interns/residents, gastroenterology/hepatology fellows, junior faculty, and visiting scholars. She also serves as Pre-Major Academic Advisor for the undergraduate school.
Her research base includes single-center Stanford-based cohorts, multi-center Bay Area consortium, multi-center US consortia as well as collaborative international cohorts.
She is active in community outreach efforts locally and nationally including service as executive board of director for nonprofit organizations. She serves in the Education and Hepatology Associate Committees for the American Association for the Study of Liver Diseases (AASLD), as member of the Steering Committee for the Hepatobiliary Neoplasia Special Interest Group at AASLD, and has served as member of the Editorial Board for various journals including Gastroenterology.
Dr. Nguyen is also active in Global Health with research collaboration and medical education program and exchanges, with ongoing work in and with several countries in the Asia Pacific region. She is Senior Fellow at the Center for Innovation in Global Health at Stanford University.
She is a Fellow of the American Association for the Study of Liver Diseases and American Gastroenterological Association Fellow, She is also a member of the European Association for the Study of Liver Diseases, the Asia Pacific Association for the Study of Liver Diseases, and the International Liver Cancer Association.
- 300 Pasteur Drive
- Stanford, CA 94305
- Phone: 650-498-7878
- 900 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-498-7999
- 900 Blake Wilbur Drive
- Palo Alto, CA 94304
- Phone: 650-736-5555
- 231 O'Connor Drive
- San Jose, CA 95128
- Phone: 650-725-1988
- 200 Jose Figueres Avenue
- Suite 255
- San Jose, CA 95116
- Phone: 650-725-1988
Practice Areas
- Alcohol Hepatitis
- Alcohol-Induced Liver Disease
- Autoimmune Hepatitis
- Chronic Liver Disease
- Cirrhosis
- Drug Induced Hepatitis
- Fatty Liver Disease
- Gallstones
- Hemochromatosis
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatology (Liver Conditions)
- Liver Cancer
- Liver Transplant
- Polycystic Liver Disease
Professional Education
- Medical Education: UCSD School of Medicine (1992) CA
- B.S., University of California, Irvine, Biological Sciences (1988)
- M.D., Univ. of California, San Diego, Medicine (1992)
- M.A.S., Univ. of Calif., San Francisco, Masters of Advanced Studies in Clinical Research (2004)
- Internship: UCSD Medical Center (1995) CA
- Residency: UCSD Medical Center (1996) CA
- Fellowship: Stanford University School of Medicine (2002) CA
- Board Certification: Transplant Hepatology, American Board of Internal Medicine (2010)
Honors & Awards
- Senior Fellow at the Center for Innovation in Global Health, Center for Innovation in Global Helath, Stanford University, Stanford, CA (2015 Oct)
- Stanford Asian American Faculty Awards, The Asian American Activities Center, Stanford University, Stanford, CA (2015 May)
- 2015 Divisional Teaching Award, Department of Medicine, Stanford University Medical Center, Palo Alto, CA (2015 Dec)
- Pacific Free Clinic Physician Service Award, Cardinal Free Clinics, Stanford University School of Medicine (2013 April)
- The Franklin Edbaugh Advising Award for Faculty, Stanford University School of Medicine (2013 May)
- Chief Fellow in Gastroenterology and Hepatology, Stanford University Medical Center (2002)
- Advanced Hepatology Research Fellow Award, American Association for the Study of Liver Diseases (2001)
- Chief Resident, University of California, San Diego Medical Center (1996)
- Excellence in Teaching Award, University of California, San Diego, School of Medicine (1996)
- Magna Cum Laude, University of California, Irvine (1988)
- Phi Beta Kappa, University of California, Irvine (1985)
Administrative Appointments
- CIGH Senior Fellow, Center for Innovation in Global Health (CIGH), Stanford University (2015 - Present)
- Steering Committee, HBV Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2015 - Present)
- Director of Hepatology Fellowship, http://med.stanford.edu/gastrohepfellows/, Stanford University Medical Center (2014 - Present)
- Steering Committee, Hepatobiliary Neoplasia Special Interest Group, American Association for the Study of Liver Diseases (AASLD) (2014 - 2016)
- Director of Hepatology Clerkship, Stanford University School of Medicine (2013 - Present)
- Executive Board of Director, Asian Health Foundation (2013 - Present)
- Liver Section Editor, Journal of Clinical Gastroenterology (2013 - Present)
- Medical Advisory Board, American Liver Foundation (2013 - Present)
- Education Committee, American Association for the Study of Liver Diseases (AASLD) (2013 - 2016)
- Hepatology Associates Committee , MD Liaison, American Association for the Study of Liver Diseases (AASLD) (2013 - 2016)
- Committee Chair, Abstract Review for Chronic Hepatitis B, American Association for the Study of Liver Diseases (AASLD) (2013 - 2013)
- Abstract review member for the Hepatitis B : Epidemiology/Prevention/Control review group, American Association for the Study of Liver Diseases (AASLD) (2011 - 2016)
- Editorial Board, Gastroenterology (2011 - 2014)
- Editorial Board, Digestive Diseases and Sciences (2008 - Present)
- Director of Continuing Medical Education, Pacific Health Foundation (2005 - 2012)
- Director of Clinical Research, Pacific Health Foundation (2004 - Present)
- Training and Workforce Committee, Member, American Association for the Study of Liver Diseases (AASLD) (2002 - 2004)
Publications
-
Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection
Nguyen, L. H., Hoang, J., Nguyen, N. H., Vu, V. D., Wang, C., & Nguyen, M. H. (2016). Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 44(4), 390-399. -
Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma
Chen, V. L., Le, A. K., Kim, N. G., Kim, L. H., Nguyen, N. H., & Nguyen, M. H. (2016). Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14(6), 887-?. -
Racial Disparities in Treatment Rates for Chronic Hepatitis C Analysis of a Population-Based Cohort of 73,665 Patients in the United States
Vutien, P., Hoang, J., Brooks, L., Nguyen, N. H., & Nguyen, M. H. (2016). Racial Disparities in Treatment Rates for Chronic Hepatitis C Analysis of a Population-Based Cohort of 73,665 Patients in the United States. MEDICINE, 95(22). -
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Nguyen, M., & Kim, W. R. (2016). Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. The American journal of gastroenterology.
-
Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
Chang, C. Y., Aziz, N., Poongkunran, M., Javaid, A., Trinh, H. N., & Nguyen, M. H. (2016). Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B. The American journal of gastroenterology.
-
Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis.
Hoang, J. K., Yang, H. I., Le, A., Nguyen, N. H., Lin, D., & Nguyen, M. H. (2016). Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis. Medicine, 95(31), e4433.
-
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients with HCV Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial.
Gane, E., Kowdley, K. V., Pound, D., Stedman, C. A., Davis, M., & Nguyen, M. H. (2016). Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients with HCV Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial. Gastroenterology.
-
Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B.
Wang, C., Chen, V., Vu, V., Le, A., Nguyen, L., & Nguyen, M. H. (2016). Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Medicine, 95(35), e4744.
-
Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States.
Yang, J. D., Altekruse, S. F., Nguyen, M. H., Gores, G. J., & Roberts, L. R. (2016). Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Cancer.
-
Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients.
Lin, D., Yang, H. I., Nguyen, N., Hoang, J., Kim, Y., & Nguyen, M. H. (2016). Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients. Alimentary pharmacology & therapeutics.
-
Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients
Devaki, P., Jencks, D., Yee, B. E., & Nguyen, M. H. (2015). Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients. HEPATOLOGY INTERNATIONAL, 9(3), 431-437.
-
Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin
Nguyen, N. H., McCormack, S. A., Vutien, P., Yee, B. E., Devaki, P., & Nguyen, M. H. (2015). Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin. INTERVIROLOGY, 58(1), 27-34.
-
Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
Yee, B. E., Nguyen, N. H., Zhang, B., Vutien, P., Wong, C. R., & Nguyen, M. H. (2014). Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin. European journal of gastroenterology & hepatology, 26(11), 1189-1201.
-
The genetic diversity and evolutionary history of hepatitis C virus in Vietnam
Li, C., Yuan, M., Lu, L., Lu, T., Xia, W., & Abe, K. (2014). The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. VIROLOGY, 468, 197-206.
-
Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks.
Nguyen, N. H., McCormack, S. A., Yee, B. E., Devaki, P., Jencks, D., & Nguyen, M. H. (2014). Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks. Hepatology international, 8(4), 540-549.
-
Low Treatment Rates in Patients Meeting Guideline Criteria in Diverse Practice Settings
Kim, L. H., Nguyen, V. G., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. H. (2014). Low Treatment Rates in Patients Meeting Guideline Criteria in Diverse Practice Settings. DIGESTIVE DISEASES AND SCIENCES, 59(9), 2091-2099.
-
Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review
Nguyen, L. H., Chao, D., Lim, J. K., Ayoub, W., & Nguyen, M. H. (2014). Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(8), 1262-1266.
-
Approximately One-Half of Patients With Early-Stage Hepatocellular Carcinoma Meeting Milan Criteria Did Not Receive Local Tumor Destructive or Curative Surgery in the Post-MELD Exception Era
Devaki, P., Wong, R. J., Marupakula, V., Nangia, S., Long Nguyen, L., & Nguyen, M. H. (2014). Approximately One-Half of Patients With Early-Stage Hepatocellular Carcinoma Meeting Milan Criteria Did Not Receive Local Tumor Destructive or Curative Surgery in the Post-MELD Exception Era. CANCER, 120(11), 1725-1732.
-
Treating hepatitis C in lower-income countries.
Jayasekera, C. R., Barry, M., Roberts, L. R., & Nguyen, M. H. (2014). Treating hepatitis C in lower-income countries. New England journal of medicine, 370(20), 1869-1871.
-
Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6
Wantuck, J. M., Ahmed, A., & Nguyen, M. H. (2014). Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(2), 137-147.
-
Less-established risk factors are common in asian americans with hepatitis C virus: a case-controlled study.
Kin, K. C., Lin, B., Chaung, K. T., Ha, N. B., Trinh, H. N., & Nguyen, M. H. (2013). Less-established risk factors are common in asian americans with hepatitis C virus: a case-controlled study. Digestive diseases and sciences, 58(11), 3342-3347.
-
Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy.
Nguyen, N. H., Nguyen, V., Trinh, H. N., Lin, B., & Nguyen, M. H. (2013). Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy. Clinical gastroenterology and hepatology , 11(5), 565-571.
-
Systematic review: Asian patients with chronic hepatitis C infection.
Nguyen, L. H., & Nguyen, M. H. (2013). Systematic review: Asian patients with chronic hepatitis C infection. Alimentary pharmacology & therapeutics, 37(10), 921-936.
-
Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice.
Lin, B., Ha, N. B., Liu, A., Trinh, H. N., Nguyen, H. A., & Nguyen, M. H. (2013). Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice. Journal of gastroenterology and hepatology, 28(5), 855-860.
-
Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B
VuTien, P., Trinh, H. N., Nguyen, K., Garcia, R. T., Nguyen, H. A., & Nguyen, M. H. (2013). Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 37(4), 464-472.
-
Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies
Mair, R. D., Valenzuela, A., Ha, N. B., Ayoub, W. S., Daugherty, T., & Nguyen, M. H. (2012). Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(12), 1412-1417.
-
Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study
Zhang, S., Ristau, J. T., Trinh, H. N., Garcia, R. T., Nguyen, H. A., & Nguyen, M. H. (2012). Undertreatment of Asian Chronic Hepatitis B Patients on the Basis of Standard Guidelines: A Community-Based Study. DIGESTIVE DISEASES AND SCIENCES, 57(5), 1373-1383.
-
Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients
Ho, E. Y., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T., & Nguyen, M. H. (2012). Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. JOURNAL OF VIRAL HEPATITIS, 19(2), E105-E111.
-
Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B
Ha, N. B., Ha, N. B., Garcia, R. T., Trinh, H. N., Chaung, K. T., & Nguyen, M. H. (2011). Medication Nonadherence with Long-Term Management of Patients with Hepatitis B e antigen-Negative Chronic Hepatitis B. DIGESTIVE DISEASES AND SCIENCES, 56(8), 2423-2431.
-
Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection
Nguyen, L. H., Ko, S., Wong, S. S., Tran, P. S., Trinh, H. N., & Nguyen, M. H. (2011). Ethnic Differences in Viral Dominance Patterns in Patients with Hepatitis B Virus and Hepatitis C Virus Dual Infection. HEPATOLOGY, 53(6), 1839-1845.
-
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery
Rhee, S.-Y., Margeridon-Thermet, S., Nguyen, M. H., Liu, T. F., Kagan, R. M., & Shafer, R. W. (2010). Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery. ANTIVIRAL RESEARCH, 88(3), 269-275.
-
Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6
Lam, K. D., Trinh, H. N., Do, S. T., Nguyen, T. T., Garcia, R. T., & Nguyen, M. H. (2010). Randomized Controlled Trial of Pegylated Interferon-Alfa 2a and Ribavirin in Treatment-Naive Chronic Hepatitis C Genotype 6. HEPATOLOGY, 52(5), 1573-1580.
-
Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans
Nguyen, N. H., Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, L. H., & Nguyen, M. H. (2010). Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans. HEPATOLOGY INTERNATIONAL, 4(2), 523-529.
-
Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting
Wong, C. R., Garcia, R. T., Trinh, H. N., Lam, K. D., Ha, N. B., & Nguyen, M. H. (2009). Adherence to Screening for Hepatocellular Carcinoma Among Patients with Cirrhosis or Chronic Hepatitis B in a Community Setting. DIGESTIVE DISEASES AND SCIENCES, 54(12), 2712-2721.
-
Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
Nguyen, M. H., Garcia, R. T., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., & Levitt, B. (2009). Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 30(11-12), 1150-1158.
-
Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels
Nguyen, M. H., Garcia, R. T., Trinh, H. N., Lam, K. D., Weiss, G., & Keeffe, E. B. (2009). Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels. AMERICAN JOURNAL OF GASTROENTEROLOGY, 104(9), 2206-2213.
-
Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil
Ha, N. B., Ha, N. B., Garcia, R. T., Trinh, H. N., Vu, A. A., & Nguyen, M. H. (2009). Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil. HEPATOLOGY, 50(3), 727-734.
-
Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation
De Luna, W., Sze, D. Y., Ahmed, A., Ha, B. Y., Ayoub, W., & Nguyen, M. H. (2009). Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 9(5), 1158-1168.
-
Clinical course of hepatitis B virus infection during pregnancy
Nguyen, G., Garcia, R. T., Nguyen, N., Trinh, H., Keeffe, E. B., & Nguyen, M. H. (2009). Clinical course of hepatitis B virus infection during pregnancy. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 29(7), 755-764.
-
Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases?
Nguyen, M. H., & Keeffe, E. B. (2008). Are Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B and HBeAg-Negative Chronic Hepatitis B Distinct Diseases?. CLINICAL INFECTIOUS DISEASES, 47(10), 1312-1314.
-
Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin
Nguyen, M. H., Trinh, H. N., Garcia, R., Nguyen, G., Lam, K. D., & Keeffe, E. B. (2008). Higher rate of sustained virologic response in chronic hepatitis C genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(5), 1131-1135.
-
Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels
Tsang, P. Sy., Trinh, H., Garcia, R. T., Phan, J. T., Ha, N. B., & Nguyen, M. H. (2008). Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 6(5), 569-574.
-
Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Cirrhosis
Nguyen, M. H., Whittemore, A. S., Garcia, R. T., Tawfeek, S. A., Ning, J., & Keeffe, E. B. (2004). Role of Ethnicity in Risk for Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Cirrhosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2(9), 820-824.
-
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis
Nguyen, M. H., Garcia, R. T., Simpson, P. W., Wright, T. L., & Keeffe, E. B. (2002). Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. HEPATOLOGY, 36(2), 410-417.
-
Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype
Lu, L., Wu, T., Xiong, L., Li, C., Nguyen, M. H., & Murphy, D. G. (2016). Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype. VIROLOGY, 492, 25-31.
-
Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy.
Chaung, K. T., O'Brien, C., Ha, N. B., Nguyen, N. H., Trinh, H. N., & Nguyen, M. H. (2016). Alternative Therapies for Chronic Hepatitis B Patients With Partial Virological Response to Standard Entecavir Monotherapy. Journal of clinical gastroenterology, 50(4), 338-344.
-
Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
Uribe, L. A., Nguyen, N., Kim, L., Trinh, H. N., Wong, C., & Nguyen, M. H. (2016). Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation. Digestive diseases and sciences, 61(2), 618-625.
-
Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice
Ha, N. B., Trinh, H. N., Rosenblatt, L., Nghiem, D., & Nguyen, M. H. (2016). Treatment Outcomes With First-line Therapies With Entecavir and Tenofovir in Treatment-Naive Chronic Hepatitis B Patients in a Routine Clinical Practice. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(2), 169-174.
-
Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice
Zhao, C., & Nguyen, M. H. (2016). Hepatocellular Carcinoma Screening and Surveillance Practice Guidelines and Real-Life Practice. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(2), 120-133.
-
Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis.
Nguyen, N. H., Yee, B. E., Chang, C., Jin, M., Lutchman, G., & Nguyen, M. H. (2016). Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis. BMJ open gastroenterology, 3(1).
-
Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study
Ahn, J., Lee, H. M., Lim, J. K., Pan, C. Q., Nguyen, M. H., & Lok, A. S. (2016). Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 43(1), 134-144.
-
Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma.
Kutsenko, A., Ladenheim, M. R., Kim, N., Nguyen, P., Chen, V., & Nguyen, M. H. (2016). Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. Journal of clinical gastroenterology.
-
Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1.
Lutchman, G., Nguyen, N. H., Chang, C. Y., Ahmed, A., Daugherty, T., & Nguyen, M. H. (2016). Effectiveness and tolerability of simeprevir and sofosbuvir in nontransplant and post-liver transplant patients with hepatitis C genotype 1. Alimentary pharmacology & therapeutics.
-
Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study.
Ladenheim, M. R., Kim, N. G., Nguyen, P., Le, A., Stefanick, M. L., & Nguyen, M. H. (2016). Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ open gastroenterology, 3(1), e000107.
-
HCV Prevalence in Asian Americans in California.
Lin, O. N., Chang, C., Lee, J., Do, A., Martin, M., & Nguyen, M. H. (2016). HCV Prevalence in Asian Americans in California. Journal of immigrant and minority health / Center for Minority Public Health.
-
Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials.
Yee, B. E., Nguyen, N. H., Jin, M., Lutchman, G., Lim, J. K., & Nguyen, M. H. (2016). Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials. BMJ open gastroenterology, 3(1).
-
Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited.
Leong, J., Lin, D., & Nguyen, M. H. (2016). Hepatitis B surface antigen escape mutations: Indications for initiation of antiviral therapy revisited. World journal of clinical cases, 4(3), 71-5.
-
Current Treatment Options in Patients with Hepatitis C Virus Genotype 6.
Nguyen, N. H., & Nguyen, M. H. (2015). Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Gastroenterology clinics of North America, 44(4), 871-881.
-
Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study
Ha, N. B., Ku, K., Ha, N. B., Chaung, K. T., Trinh, H. N., & Nguyen, M. H. (2015). Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study. JOURNAL OF CLINICAL GASTROENTEROLOGY, 49(10), 873-877.
-
Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy
Kim, L. H., Chaung, K. T., Ha, N. B., Kin, K. C., Vu, V. D., & Nguyen, M. H. (2015). Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 27(8), 871-876.
-
Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir
Lu, L., Yip, B., Trinh, H., Pan, C. Q., Han, S.-H. B., & Nguyen, M. H. (2015). Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir. JOURNAL OF VIRAL HEPATITIS, 22(8), 675-681.
-
Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation
Ku, W., Wang, U., & Nguyen, M. H. (2015). Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation. EXPERT OPINION ON BIOLOGICAL THERAPY, 15(5), 665-677.
-
Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1
Kumari, R., & Nguyen, M. H. (2015). Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1. EXPERT OPINION ON PHARMACOTHERAPY, 16(5), 739-748.
-
Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir
Vo, K. P., Vutien, P., Akiyama, M. J., Vu, V. D., Ha, N. B., & Nguyen, M. H. (2015). Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. DIGESTIVE DISEASES AND SCIENCES, 60(4), 1045-1051.
-
Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy
Valenzuela, A., Ha, N. B., Gallo, A., Bonham, C., Ahmed, A., & Nguyen, M. H. (2015). Recurrent Hepatocellular Carcinoma and Poorer Overall Survival in Patients Undergoing Left-sided Compared With Right-sided Partial Hepatectomy. JOURNAL OF CLINICAL GASTROENTEROLOGY, 49(2), 158-164.
-
Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings
Nguyen, V. G., Wan, K., Trinh, H. N., Li, J., Zhang, J. Q., & Nguyen, M. H. (2015). Chronic Hepatitis B Treatment Eligibility and Actual Treatment Rates in Patients in Community Gastroenterology and Primary Care Settings. JOURNAL OF CLINICAL GASTROENTEROLOGY, 49(2), 145-149.
-
Safety and efficacy of entecavir in adefovir-experienced patients
Nguyen, N. H., Trinh, H. N., Nguyen, T. T., Do, S. T., Tran, P., & Nguyen, M. H. (2015). Safety and efficacy of entecavir in adefovir-experienced patients. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30(1), 43-50.
-
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., & Ruane, P. J. (2015). Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. The New England journal of medicine, 373(27), 2599-607.
-
Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis
Zhang, B., Nguyen, N. H., Yee, B. E., Yip, B., Ayoub, W. S., & Nguyen, M. H. (2015). Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. INTERVIROLOGY, 58(4), 242-249.
-
Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis.
Yee, B. E., Nguyen, N. H., Zhang, B., Lin, D., Vutien, P., & Nguyen, M. H. (2015). Sustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis. BMJ open gastroenterology, 2(1).
-
Current Treatment Options in Patients with Hepatitis C Virus Genotype 6
Nguyen, N. H., & Nguyen, M. H. (2015). Current Treatment Options in Patients with Hepatitis C Virus Genotype 6. Gastroenterol Clin N Am, 44.
-
Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care.
Vu, V. D., Do, A., Nguyen, N. H., Kim, L. H., Trinh, H. N., & Nguyen, M. H. (2015). Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ open gastroenterology, 2(1).
-
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
Martin, P., Lau, D. T., Nguyen, M. H., Janssen, H. L., Dieterich, D. T., & Jacobson, I. M. (2015). A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
-
Current Treatment Guidelines for Chronic Hepatitis B and Their Applications
Uribe, L. A., O'Brien, C. G., Wong, R. J., Gish, R. R., Tsai, N., & Nguyen, M. H. (2014). Current Treatment Guidelines for Chronic Hepatitis B and Their Applications. JOURNAL OF CLINICAL GASTROENTEROLOGY, 48(9), 773-783.
-
Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score
Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(9), 1534-U323.
-
Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score.
Wong, R. J., Devaki, P., Nguyen, L., Cheung, R., Cho-Phan, C., & Nguyen, M. H. (2014). Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score. Clinical gastroenterology and hepatology , 12(9), 1534-1540 e1.
-
Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients
Vutien, P., Trinh, H. N., Garcia, R. T., Nguyen, H. A., Levitt, B. S., & Nguyen, M. H. (2014). Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 12(8), 1363-1370.
-
Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies
Do, A. L., Wong, C. R., Nguyen, L. H., Nguyen, V. G., Huy Trinh, H., & Nguyen, M. H. (2014). Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. JOURNAL OF CLINICAL GASTROENTEROLOGY, 48(7), 644-649.
-
Isoniazid hepatotoxicity requiring liver transplantation.
Sheen, E., Huang, R. J., Uribe, L. A., & Nguyen, M. H. (2014). Isoniazid hepatotoxicity requiring liver transplantation. Digestive diseases and sciences, 59(7), 1370-1374.
-
Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
Gao, L., Trinh, H. N., Li, J., & Nguyen, M. H. (2014). Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply. Alimentary pharmacology & therapeutics, 39(11), 1339-1340.
-
Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply.
Wantuck, J. M., & Nguyen, M. H. (2014). Letter: Response-guided treatment of hepatitis C virus genotype 5 may be feasible--authors' reply. Alimentary pharmacology & therapeutics, 39(11), 1338-?.
-
Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry
Wong, R. J., Devaki, P., Long Nguyen, L., Cheung, R., & Nguyen, M. H. (2014). Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry. LIVER TRANSPLANTATION, 20(5), 528-535.
-
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., & Kwo, P. (2014). Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. New England journal of medicine, 370(16), 1483-1493.
-
Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA
Gao, L., Trinh, H. N., Li, J., & Nguyen, M. H. (2014). Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(6), 629-637.
-
Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase <= 40 IU/L and significant hepatic fibrosis
Chao, D. T., Lim, J. K., Ayoub, W. S., Nguyen, L. H., & Nguyen, M. H. (2014). Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase <= 40 IU/L and significant hepatic fibrosis. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(4), 349-358.
-
Primary Surgical Resection Versus Liver Transplantation for Transplant-Eligible Hepatocellular Carcinoma Patients
Wong, R. J., Wantuck, J., Valenzuela, A., Ahmed, A., Bonham, C., & Nguyen, M. H. (2014). Primary Surgical Resection Versus Liver Transplantation for Transplant-Eligible Hepatocellular Carcinoma Patients. DIGESTIVE DISEASES AND SCIENCES, 59(1), 183-191.
-
The genetic diversity and evolutionary history of hepatitis C virus in Vietnam.
Li, C., Yuan, M., Lu, L., Lu, T., Xia, W., & Abe, K. (2014). The genetic diversity and evolutionary history of hepatitis C virus in Vietnam. Virology, 468-470C, 197-206.
-
Management of Chronic hepatitis C among Asian Americans.
Yip, B., Nguyen, L. H., & Nguyen, M. H. (2014). Management of Chronic hepatitis C among Asian Americans. . North Am J Med Sci. , 7.
-
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.
Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., & Gitlin, N. (2014). Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. The New England journal of medicine, 370(20), 1889-98.
-
Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.
Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., & Bernstein, D. E. (2014). Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. The New England journal of medicine, 370(20), 1879-88.
-
Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Na < ve Chronic Hepatitis B Patients: A Case-Control Study
Ha, N. B., Ha, N. B., Chaung, K. T., Trinh, H. N., Nguyen, H. A., & Nguyen, M. H. (2014). Similar Response to Entecavir 0.5 and 1.0 Mg in Treatment-Na < ve Chronic Hepatitis B Patients: A Case-Control Study. DIGESTIVE DISEASES AND SCIENCES, 59(1), 168-173.
-
Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma
Yip, B., Wantuck, J. M., Kim, L. H., Wong, R. J., Ahmed, A., & Nguyen, M. H. (2014). Clinical Presentation and Survival of Asian and Non-Asian Patients with HCV-Related Hepatocellular Carcinoma. DIGESTIVE DISEASES AND SCIENCES, 59(1), 192-200.
-
Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians
Lin, H., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., & Nguyen, M. H. (2013). Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians. JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 15(6), 1023-1029.
-
Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics
Ku, K. C., Li, J., Ha, N. B., Martin, M., Nguyen, V. G., & Nguyen, M. H. (2013). Chronic Hepatitis B Management Based on Standard Guidelines in Community Primary Care and Specialty Clinics. DIGESTIVE DISEASES AND SCIENCES, 58(12), 3626-3633.
-
Prevention of mother-to-child transmission of hepatitis B virus: is elective cesarean section in highly viremic mothers an appropriate adjunct to immunoprophylaxis?
Nguyen, L. H., & Nguyen, M. H. (2013). Prevention of mother-to-child transmission of hepatitis B virus: is elective cesarean section in highly viremic mothers an appropriate adjunct to immunoprophylaxis?. Clinical gastroenterology and hepatology , 11(10), 1356-1357.
-
Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California
Ha, N. B., Trinh, H. N., Nguyen, T. T., Leduc, T.-S., Bui, C., & Nguyen, M. H. (2013). Prevalence, Risk Factors, and Disease Knowledge of Chronic Hepatitis B Infection in Vietnamese Americans in California. JOURNAL OF CANCER EDUCATION, 28(2), 319-324.
-
Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily
Ha, N. B., Ha, N. B., Trinh, H. N., Nguyen, H. A., Nguyen, K. K., & Nguyen, M. H. (2013). Response to Higher Dose of Entecavir 1.0 mg Daily in Patients With Partial Response to Entecavir 0.5 mg Daily. JOURNAL OF CLINICAL GASTROENTEROLOGY, 47(5), 461-465.
-
High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints
Kin, K. C., Lin, B., Ha, N. B., Chaung, K. T., Trinh, H. N., & Nguyen, M. H. (2013). High Proportion of Hepatitis C Virus in Community Asian American Patients With Non-Liver-related Complaints. JOURNAL OF CLINICAL GASTROENTEROLOGY, 47(4), 367-371.
-
Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice
Liu, A., Ha, N. B., Lin, B., Yip, B., Trinh, H. N., & Nguyen, M. H. (2013). Low hepatitis B envelope antigen seroconversion rate in chronic hepatitis B patients on long-term entecavir 0.5 mg daily in routine clinical practice. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 25(3), 338-343.
-
Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies.
Do, A. L., Wong, C. R., Nguyen, L. H., Nguyen, V. G., Trinh, H., & Nguyen, M. H. (2013). Hepatocellular Carcinoma Incidence in Noncirrhotic Patients With Chronic Hepatitis B and Patients With Cirrhosis of All Etiologies. Journal of clinical gastroenterology.
-
High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy
Chaung, K. T., Ha, N. B., Trinh, H. N., Garcia, R. T., Nguyen, H. A., & Nguyen, M. H. (2012). High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy. JOURNAL OF CLINICAL GASTROENTEROLOGY, 46(10), 865-870.
-
Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders
Yip, B., Chaung, K., Wong, C. R., Trinh, H. N., Nguyen, H. A., & Nguyen, M. H. (2012). Tenofovir Monotherapy and Tenofovir Plus Entecavir Combination as Rescue Therapy for Entecavir Partial Responders. DIGESTIVE DISEASES AND SCIENCES, 57(11), 3011-3016.
-
Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study
Ha, N. B., Ha, N. B., Ahmed, A., Ayoub, W., Daugherty, T. J., & Nguyen, M. H. (2012). Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. CANCER CAUSES & CONTROL, 23(3), 455-462.
-
Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection
Nguyen LH, & Nguyen MH. (2012). Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection. Hepatology, 55.
-
High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure
Wong, C. R., Trinh, H. N., Yip, B., Nguyen, H. A., Garcia, R. T., & Nguyen, M. H. (2011). High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure. JOURNAL OF CLINICAL GASTROENTEROLOGY, 45(10), 900-905.
-
The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir
SHEEN, E., Trinh, H. N., Nguyen, T. T., Do, S. T., Tran, P., & Nguyen, M. H. (2011). The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 34(7), 767-774.
-
Systematic review: epidemiology of hepatitis C genotype 6 and its management
Chao, D. T., Abe, K., & Nguyen, M. H. (2011). Systematic review: epidemiology of hepatitis C genotype 6 and its management. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 34(3), 286-296.
-
The role of steatosis in HBV infection
Lim JK, & Nguyen MH. (2011). The role of steatosis in HBV infection. Curr Hepat Rep, 10.
-
Relationship between HBsAg seroconversion and hepatocellular carcinoma
Lutchman G, & Nguyen MH. (2011). Relationship between HBsAg seroconversion and hepatocellular carcinoma. J Clin Gastroenterol, 45.
-
Early virologic response in HCV genotype 6
Lam KD, & Nguyen MH. (2011). Early virologic response in HCV genotype 6. Hepatology, 53.
-
Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6
Nguyen, N. H., VuTien, P., Garcia, R. T., Trinh, H., Nguyen, H., & Nguyen, M. H. (2010). Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6. JOURNAL OF VIRAL HEPATITIS, 17(10), 691-697.
-
Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C
Vutien, P., Nguyen, N. H., Trinh, H. N., Li, J., Garcia, R. T., & Nguyen, M. H. (2010). Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C. AMERICAN JOURNAL OF GASTROENTEROLOGY, 105(5), 1110-1115.
-
Histologic Disease in Patients with Chronic Hepatitis B, HIgh HBV DNA, and Normal Alanine Aminotransferase Levels
Lim JK, Ayoub WS, & Nguyen MH. (2010). Histologic Disease in Patients with Chronic Hepatitis B, HIgh HBV DNA, and Normal Alanine Aminotransferase Levels. Curr Hepat Rep, 9.
-
Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding
Ayoub, W. S., & Nguyen, M. H. (2009). Combination of pharmacologic and endoscopic therapy for the secondary prevention of esophageal variceal bleeding. GASTROINTESTINAL ENDOSCOPY, 70(4), 665-667.
-
Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B
Nguyen, L. H., Ha, N. B., Vutien, P., Ha, N. B., Garcia, R. T., & Nguyen, M. H. (2009). Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B. HEPATOLOGY INTERNATIONAL, 3(3), 461-467.
-
alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., & Schwartz, M. (2009). alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma. GASTROENTEROLOGY, 137(1), 110-118.
-
Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides
Nguyen, M. H., & Keeffe, E. B. (2009). Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides. JOURNAL OF VIRAL HEPATITIS, 16(3), 149-155.
-
Hepatitis C virus and cancers: How strong are the relationships?
Lutchman G, & Nguyen MH. (2009). Hepatitis C virus and cancers: How strong are the relationships?. Curr Hepat Rep, 8.
-
Prevalence of Colorectal Neoplasms in Asian Americans
Lam, K. D., Garcia, R. T., Nguyen, L. H., Trinh, H., Triadafilopoulos, G., & Nguyen, M. H. (2009). Prevalence of Colorectal Neoplasms in Asian Americans. DIGESTIVE DISEASES AND SCIENCES, 54(1), 160-167.
-
Low proportion of Barrett's esophagus in Asian Americans
Lam, K. D., Phan, J. T., Garcia, R. T., Trinh, H., Nguyen, H., & Nguyen, M. H. (2008). Low proportion of Barrett's esophagus in Asian Americans. AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(7), 1625-1630.
-
Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion
Ha, B. Y., Ahmed, A., Sze, D. Y., Razavi, M. K., Simpson, N., & Nguyen, M. H. (2007). Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 26(6), 839-846.
-
Chronic HBV infection and normal ALT levels: Underlying histological disease
Hoda K, & Nguyen MH. (2007). Chronic HBV infection and normal ALT levels: Underlying histological disease. Curr Hepat Rep, 6.
-
Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.
Nguyen, M. H., & Keeffe, E. B. (2005). Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clinical gastroenterology and hepatology , 3(10), S97-S101.
-
Chronic hepatitis C: genotypes 4 to 9.
Nguyen, M. H., & Keeffe, E. B. (2005). Chronic hepatitis C: genotypes 4 to 9. Clinics in liver disease, 9(3), 411-?.
-
The diagnosis and management of benign hepatic tumors
Choi, B. Y., & Nguyen, M. H. (2005). The diagnosis and management of benign hepatic tumors. JOURNAL OF CLINICAL GASTROENTEROLOGY, 39(5), 401-412.
-
General management
Nguyen, M. H., & Keeffe, E. B. (2005). General management. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY, 19(1), 161-174.
-
Benign tumors and evaluation of liver masses
Nguyen MH, & Keeffe EB. (2005). Benign tumors and evaluation of liver masses. In: Al Knawy B, Schiffman ML, and Wiesner R, eds. Hepatology: A Practical Approach, 1st ed. Amsterdam: Elsevier Science BV..
-
Lead poisoning as an etiology of abdominal pain and intestinal pseudo-obstruction in adults
Tran, C. P., Garcia, R. T., Lam, V. T., Trong, T. H., Keeffe, E. B., & Nguyen, M. H. (2004). Lead poisoning as an etiology of abdominal pain and intestinal pseudo-obstruction in adults. AMERICAN JOURNAL OF GASTROENTEROLOGY, 99(10), S105-S105.
-
Use of endoclips in the treatment of massive colonic diverticular bleeding
Simpson, P. W., Nguyen, M. H., Lim, J. K., & Soetikno, R. M. (2004). Use of endoclips in the treatment of massive colonic diverticular bleeding. GASTROINTESTINAL ENDOSCOPY, 59(3), 433-437.
-
Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9.
Nguyen, M. H., & Keeffe, E. B. (2004). Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Reviews in gastroenterological disorders, 4, S14-21.
-
Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: A multicenter randomized trial
Garcia, R. T., Cello, J. P., Nguyen, M. H., Rogers, S. J., Rodas, A., & McQuaid, K. R. (2003). Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: A multicenter randomized trial. GASTROENTEROLOGY, 125(6), 1606-1612.
-
Prophylactic clip application
Nguyen, M. H., & Soetikno, R. (2003). Prophylactic clip application. GASTROINTESTINAL ENDOSCOPY, 58(6), 941-941.
-
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine
Simpson, N. D., Simpson, P. W., Ahmed, A. M., Nguyen, M. H., Garcia, G., & Ahmed, A. (2003). Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine. JOURNAL OF CLINICAL GASTROENTEROLOGY, 37(1), 68-71.
-
Chronic hepatitis B and hepatitis C in Asian Americans.
Nguyen, M. H., & Keeffe, E. B. (2003). Chronic hepatitis B and hepatitis C in Asian Americans. Reviews in gastroenterological disorders, 3(3), 125-134.
-
Treatment of Hepatocellular Carcinoma
Nguyen MH, & Keeffe EB. (2003). Treatment of Hepatocellular Carcinoma. Rustgi AK and Crawford J, eds. Gastrointestinal Cancer: A companion to Sleisenger & Fordtran?s GI and liver diseases. Philadelphia: WB Saunders, 1st ed.
-
Screening for hepatocellular carcinoma
Nguyen, M. H., & Keeffe, E. B. (2002). Screening for hepatocellular carcinoma. JOURNAL OF CLINICAL GASTROENTEROLOGY, 35(5), S86-S91.
-
Unsedated ultrathin EGD is well accepted by most patients: A randomized trial of unsedated ultrathin EGD (UT-EGD) vs. sedated conventional EGD (C-EGD)
Garcia, R. T., Cello, J. P., Rogers, S. J., Rodas, A., Nguyen, M. H., & McQuaid, K. R. (2002). Unsedated ultrathin EGD is well accepted by most patients: A randomized trial of unsedated ultrathin EGD (UT-EGD) vs. sedated conventional EGD (C-EGD). AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(9), S306-S306.
-
Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?
Nguyen, M. H., & Garcia, G. (2002). Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?. AMERICAN JOURNAL OF GASTROENTEROLOGY, 97(5), 1092-1093.
-
Therapeutic advances in the management of hepatitis B and hepatitis C
Nguyen, M. H., & Wright, T. L. (2001). Therapeutic advances in the management of hepatitis B and hepatitis C. CURRENT OPINION IN INFECTIOUS DISEASES, 14(5), 593-601.
-
DIFFERENTIAL MIGRATION OF ASTROCYTES GRAFTED INTO THE DEVELOPING RAT-BRAIN
Hatton, J. D., Nguyen, M. H., & U, H. S. (1993). DIFFERENTIAL MIGRATION OF ASTROCYTES GRAFTED INTO THE DEVELOPING RAT-BRAIN. GLIA, 9(2), 113-119.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Apr 2016
She is a good listener, also she explain clearly the plan she will do with me.
SHC Patient, Mar 2016
Dr. Nguyen was great!! Same caliber as Dr. Ayoub who is no longer with you.
SHC Patient, Mar 2016
I fill very comfortable and confident
SHC Patient, Nov 2015
Best experience.
SHC Patient, Nov 2015
Dr. Mindie Nguyen is a SAINT!!
SHC Patient, Oct 2015
Perhaps it is that my health condition is in excellent shape. Hence, my doctor does not really show much of concern on my Hep-B test results.
SHC Patient, Aug 2015
Very Good
SHC Patient, Jul 2015
Excellent
SHC Patient, Jun 2015
Great, knowledgeable, compassionate doctor!
SHC Patient, Jun 2015
our care provider that day is the absolute BEST!!! We have complete confidence in her.
SHC Patient, May 2015
Excellent
SHC Patient, May 2015
Dr. Nyugen is extremely knowledgeable and easy to converse with
SHC Patient, Feb 2015
Very good!
SHC Patient, Sep 2014
I have been a patient with Dr. Nguyen for a very long time. She has always made me feel that I was being cared for with the utmost ability. I would recommend her to anybody -
SHC Patient, Jul 2014
Good.
SHC Patient, Jun 2014
Mindy has been my doctor for a long time. She has been concerned in the best way possible about me in categories of my health.
SHC Patient, May 2014
Dr. Nguyen is superb! Very social - Enjoy talking with her during visits.
SHC Patient, Mar 2014
Good - doctor to have, to keep.
SHC Patient, Feb 2014
I liked the fact that she printed out all the instructions.
SHC Patient, Feb 2014
Good.
SHC Patient, Apr 2016
She is a good listener, also she explain clearly the plan she will do with me.
SHC Patient, Mar 2016
Dr. Nguyen was great!! Same caliber as Dr. Ayoub who is no longer with you.
SHC Patient, Mar 2016
I fill very comfortable and confident
SHC Patient, Nov 2015
Best experience.
SHC Patient, Nov 2015
Dr. Mindie Nguyen is a SAINT!!
SHC Patient, Oct 2015
Perhaps it is that my health condition is in excellent shape. Hence, my doctor does not really show much of concern on my Hep-B test results.
SHC Patient, Aug 2015
Very Good
SHC Patient, Jul 2015
Excellent
SHC Patient, Jun 2015
Great, knowledgeable, compassionate doctor!
SHC Patient, Jun 2015
our care provider that day is the absolute BEST!!! We have complete confidence in her.
SHC Patient, May 2015
Excellent
SHC Patient, May 2015
Dr. Nyugen is extremely knowledgeable and easy to converse with
View All 20 Patient Comments »